Recently, ACROBiosystems has officially received the 'Material Suitability Confirmation for Regenerative Medicine Products' (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices ...

NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) ("NeOnc" or the "Company"), a clinical-stage life sciences company focused ...

The future of cell and gene therapy may be defined less by discoveries and more by how the industry connects research and ...

Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered ...

PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and ...

Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in ...

Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

SHANGHAI, June 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance ...

VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...

Kusumgar's Rs 650-crore IPO concluded with overwhelming investor demand on its final day. Non-Institutional Investors and ...